The early ticking of the central circadian pacemaker: when and how

StarTicking aims to uncover the development and functionality of the circadian clock in mice and humans, linking early environmental factors to behavioral outcomes in pre-term infants.

Subsidie
€ 1.955.875
2024

Projectdetails

Introduction

The 24-h (circadian) timing system develops during the perinatal period and rules our physiology later in life. It has the essential task of anticipating daily recurring changes in the environment (day/night) to find the best time for each molecular and cellular process.

Hierarchical Organization

It is organised hierarchically, with a master pacemaker in the hypothalamic suprachiasmatic nucleus (SCN), which is able to perceive environmental light and tell the body what time it is. Our modern 24/7 lifestyle favours a disruptive environment for the circadian system, which is especially negative during pregnancy.

Findings on Glucocorticoids

We have found, in mice and pre-term infants, that when mothers are exposed to glucocorticoids (GCs) at the wrong time of day, the offspring show behaviour disorders later in life. Our mechanistic findings showed for the first time a role of the foetal clock before birth, challenging the view on the clock being immature and non-functional.

Research Goals

StarTicking proposes to answer a long-standing question in the field: When and how does the circadian clock start ticking? With a multidisciplinary and integrated approach, we will go beyond the state-of-the-art to understand mechanistically the development of the central circadian pacemaker in mice and humans.

Investigation Areas

We will investigate:

  1. How the SCN forms by a detailed assessment of the developmental trajectory of the mouse SCN with single cell resolution.
  2. When the SCN becomes functional by testing a yet unexplored player: Astrocytes as drivers of the gain of functionality of the mouse SCN.
  3. What the influence of the early environment on the human SCN maturation is. The generation of a human SCN organoid will allow us to test maternal signals in vitro with high-throughput.

Linking Findings to Development

We will link mechanistic findings to the development of SCN-driven rhythms in a cohort of pre-term babies. StarTicking will provide ground-breaking mechanistic evidence and valuable knowledge to alleviate the behavioural consequences of the circadian disruption early in life.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 1.955.875
Totale projectbegroting€ 1.955.875

Tijdlijn

Startdatum1-1-2024
Einddatum31-12-2028
Subsidiejaar2024

Partners & Locaties

Projectpartners

  • ACHUCARRO BASQUE CENTER FOR NEUROSCIENCE FUNDAZIOApenvoerder

Land(en)

Spain

Vergelijkbare projecten binnen European Research Council

ERC Advanced...

Targeting the circadian clock in personalized disease prevention

This project aims to identify and mitigate health risks associated with disrupted circadian rhythms in night workers through genetic profiling and targeted interventions for healthier aging.

€ 2.499.965
ERC Proof of...

Pre-commercialization of circadian clock-drug interactions screening tool for therapeutic applications

The CIRCOMMUNICATION project aims to commercialize CircaSCOPE, a high-throughput method for constructing Phase Transition Curves to enhance drug efficacy and minimize side effects through chronotherapy.

€ 150.000
ERC Starting...

Map and manipulate sleep oscillations to reveal their role in healthy cognitive development

This project aims to investigate the causal relationship between sleep architecture and cognitive development in young mammals using advanced neurobiological techniques to inform therapeutic strategies for developmental disorders.

€ 1.500.000
ERC Starting...

Investigating the Molecular identity of PAcemaker neurons in CorTical development

IMPACT aims to explore how cortical neuronal diversity affects early spontaneous activity and identify pacemaker neurons' roles, potentially leading to new interventions for perinatal disorders.

€ 1.490.000
ERC Starting...

Co-option of host circadian rhythms in cancer

INN-TIME aims to uncover how tumors exploit circadian rhythms of innate immune and stromal cells to evade anti-tumoral defenses, paving the way for novel cancer therapies.

€ 1.500.000